Bio-Techne Corporation reported earnings results for the full year ended June 30, 2022. For the full year, the company reported sales was USD 1,105.6 million compared to USD 931.03 million a year ago. Net income was USD 272.05 million compared to USD 140.41 million a year ago.

Basic earnings per share from continuing operations was USD 1.7325 compared to USD 0.905 a year ago. Diluted earnings per share from continuing operations was USD 1.6575 compared to USD 0.8675 a year ago.